Exploring intravenous injection behaviors knowledge and drug preferences of individuals injecting prescription opioids or prescription stimulants
Ended Awarded Last action
- Contract number
- 75F40121F19014
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $886,772
Award facts
- Opportunity
-
- FDA21RFQ1239690 Solicitation number
- Contract value 100% obligated
- $886,772.29 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$6,661 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $893,433 |
About this award
This contract award from the Food and Drug Administration to Research Triangle Institute (RTI International) supported research exploring intravenous injection behaviors, knowledge, and drug preferences among individuals injecting prescription opioids or prescription stimulants. Valued at $886,772.29 on a firm fixed price basis, the work was performed in Silver Spring, Maryland under a Blanket Purchase Agreement (BPA) call with an ultimate completion date of September 30, 2025. The contract was awarded on August 25, 2021, with no set-aside designation. RTI International, a prominent non-profit research organization based in Research Triangle Park, North Carolina, brought its multidisciplinary expertise in public health research and substance abuse prevention to this initiative, which aligns with FDA's regulatory and public health mission.
A subcontract valued under this prime award was issued to the University of North Carolina at Chapel Hill's Office of Sponsored Research on August 29, 2022 (Subcontract 6-312-0217597). The contract has subsequently entered closeout status, with the current modification intended to de-obligate remaining funds and formally conclude the award. This collaborative arrangement between RTI International and UNC-Chapel Hill leveraged complementary research capabilities to advance understanding of injection drug use patterns and substance abuse behaviors, supporting evidence-based policy and public health interventions within FDA's regulatory framework.
Quick answers
Who was awarded contract 75F40121F19014?
75F40121F19014 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on August 25, 2021.
How much is contract 75F40121F19014 worth?
The government has obligated $886,772 on 75F40121F19014.
Is contract 75F40121F19014 an order under another contract?
Yes. 75F40121F19014 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19014 competed?
The extent of competition for 75F40121F19014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award